Utah Medical Products Inc (UTMD) Stock Price

UTMDStock

$74.51+24.02%52W

Market Cap$236.48M

P/E20.95x

PEG Ratio4.25

Div yield1.45%

Beta0.40

UTMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-0.93%

Price vs S&P 500 (4W)1.37%

PEG Ratio4.25

VGM Score52.86

P/E Ratio (Annual)20.95x

Indicated Dividend Yield (Annual)1.45%

P/CF (Annual)16.10x

Book Value / Share (Quarterly)$38.34

P/TBV (Annual)1.51x

Indicated Dividend (Annual)$1.24

Revenue Growth (3Y)-9.68%

Cash Flow / Share (Quarterly)$3.60

Payout Ratio (TTM)37.58%

Price vs S&P 500 (YTD)21.22%

Gross Margin (TTM)57.90%

Net Profit Margin (TTM)29.04%

EPS (TTM)$3.28

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$3.28

Revenue Growth (5Y)-1.80%

EPS (Annual)$3.48

Dividend / Share (Annual)$1.22

ROI (Annual)9.46%

Gross Margin (Annual)57.12%

Net Profit Margin (5Y Avg)31.60%

Cash / Share (Quarterly)$27.50

P/E Basic Excl Extra (TTM)22.55x

Revenue Growth QoQ (YoY)-14.31%

EPS Growth (5Y)3.43%

P/E Normalized (Annual)20.95x

ROA (Last FY)9.21%

Revenue Growth TTM (YoY)-7.00%

EBITD / Share (TTM)$3.48

ROE (5Y Avg)12.49%

Operating Margin (TTM)28.43%

Cash Flow / Share (Annual)$4.50

P/B Ratio1.94x

P/B Ratio (Quarterly)1.80x

Net Income / Employee (Annual)$80,600

EV / Revenue (TTM)4.13x

Net Interest Coverage (TTM)260.17x

ROA (TTM)8.50%

EPS Growth QoQ (YoY)-10.16%

EV / EBITDA (TTM)13.41x

EPS Incl Extra (Annual)$3.48

Current Ratio (Annual)37.62x

Quick Ratio (Quarterly)44.01x

3-Month Avg Trading Volume0.03M

52-Week Price Return24.02%

EV / Free Cash Flow (Annual)10.40x

P/E Incl Extra (TTM)22.55x

Revenue / Employee (TTM)$257,900

Tangible BV / Share (Quarterly)$38.23

P/S Ratio (Annual)6.14x

Asset Turnover (Annual)0.31x

52-Week High$76.89

Operating Margin (5Y Avg)34.51%

EPS Excl Extra (Annual)$3.48

CapEx CAGR (5Y)-15.48%

Tangible BV CAGR (5Y)8.49%

26-Week Price Return8.98%

Quick Ratio (Annual)34.36x

13-Week Price Return6.75%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)48.62x

Enterprise Value$148.95M

Revenue / Share Growth (5Y)0.68%

Asset Turnover (TTM)0.29x

Book Value / Share Growth (5Y)5.56%

Revenue / Employee (Annual)$275,100

Inventory Turnover (Annual)1.97x

Pretax Margin (Annual)36.63%

Cash / Share (Annual)$26.92

3-Month Return Std Dev28.54%

Gross Margin (5Y Avg)60.12%

Net Income / Employee (TTM)$74,900

EBITDA CAGR (5Y)-1.24%

EBITDA Interim CAGR (5Y)-10.36%

ROE (Last FY)9.46%

Net Interest Coverage (Annual)64.83x

EPS Basic Excl Extra (Annual)$3.48

P/FCF (TTM)20.66x

Receivables Turnover (TTM)10.03x

EV / Free Cash Flow (TTM)13.01x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$3.28

Receivables Turnover (Annual)10.12x

ROI (TTM)8.74%

Dividend Growth Rate (5Y)1.59%

P/S Ratio (TTM)6.55x

Pretax Margin (5Y Avg)39.22%

Revenue / Share (Annual)$11.89

Tangible BV / Share (Annual)$37.17

Free OCF CAGR (5Y)-5.77%

Price vs S&P 500 (52W)8.49%

P/E Ratio (TTM)22.55x

EPS Growth TTM (YoY)-12.17%

Year-to-Date Return33.15%

5-Day Price Return0.13%

EPS Normalized (Annual)$3.48

ROA (5Y Avg)11.78%

Net Profit Margin (Annual)29.30%

Month-to-Date Return0.62%

Cash Flow / Share (TTM)$6.58

EBITD / Share (Annual)$4.17

EPS Growth (3Y)-8.35%

Operating Margin (Annual)29.60%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)19.96x

ROI (5Y Avg)12.49%

P/E Excl Extra (TTM)22.55x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$3.28

P/TBV (Quarterly)1.80x

Payout Ratio (Annual)35.29%

P/B Ratio (Annual)1.50x

Dividend / Share (TTM)$1.23

Inventory Turnover (TTM)1.76x

Pretax Margin (TTM)35.68%

Book Value / Share (Annual)$37.44

Price vs S&P 500 (13W)4.06%

Net Margin Growth (5Y)2.74%

Dividend Yield (TTM)1.67%

Beta0.40x

P/FCF (Annual)16.51x

Revenue / Share (TTM)$11.34

ROE (TTM)8.74%

52-Week Low$53.66

vGradeB

gGradeD

mGradeB

vgmGradeC

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
UTMDUtah Medical Products Inc	B	D	B	6.5x	-1.8%	57.9%	28.4%	$74.51
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Utah Medical Products Inc

Utah Medical Products Inc manufactures and distributes proprietary disposable medical devices for hospitals and clinical settings. Its product portfolio addresses critical care, obstetrics, urology, and electrosurgery applications, including blood pressure monitoring systems, electrosurgical pens, and blood collection devices. The company serves hospital departments, outpatient clinics, and physician offices.